Luzu Approval History
FDA Approved: Yes (First approved November 14, 2013)
Brand name: Luzu
Generic name: luliconazole
Dosage form: Topical Cream
Company: Bausch Health Companies Inc.
Treatment for: Tinea Corporis, Tinea Pedis, Tinea Cruris
Luzu (luliconazole) Cream is an azole antifungal indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis.
Development History and FDA Approval Process for Luzu
|Feb 22, 2018||FDA Approves Expanded Use of Luzu (luliconazole) Cream in Pediatric Patients with Athlete’s Foot, Jock Itch and Ringworm|
|Nov 15, 2013||Valeant Pharmaceuticals Announces U.S. Approval Of Luzu Cream, 1%|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.